Elevated GRP78 levels in patients with ovarian cancer are associated with poor prognosis; they are also weakly expressed in cisplatin-sensitive ovarian cancer cells, mediating cisplatin-induced senescence (56). The gene discussed is HSPA5; the disease is ovarian cancer.